More importantly, in certain cancer types, including gastric cancer and non-small cell lung cancer, TrxR1 appeared to be secreted into the serum and may be available as a biomarker of disease severity and responsiveness to treatment (38, 39). The gene discussed is TXNRD1; the disease is non-small cell lung carcinoma.